Specific caspase-10 inhibitors
US8357721B2 · kind B2 · utility
0Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2006 |
| Grant date | Jan 22, 2013 |
| Priority date | — |
| Expiry date | Dec 17, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of the general formula (I) wherein R1, R2, R3, R4, R5, R6, i and j have the meanings given in claim 1, and to the use thereof as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.